Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement

NCT00508326 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: Paclitaxel

Sponsor

M.D. Anderson Cancer Center